津药药业：子公司获得复方氨基酸双肽注射液药品注册证书

Core Viewpoint - Tianjin Pharmaceutical Industry (津药药业) announced that its subsidiary, Tianjin Pharmaceutical Peace (津药和平), has received the drug registration certificate for Compound Amino Acid (15) Dipeptide (2) Injection from the National Medical Products Administration [1] Group 1 - The approval of the drug registration certificate marks a significant regulatory milestone for the company [1] - The Compound Amino Acid Injection is expected to enhance the company's product portfolio and market competitiveness [1]